OVERVIEW OF CHARACTERISTICS OF ADHERENCE TO TREATMENT OF ALLERGIC RHINITIS

Tu Minh Hoang Le, Thi Hoai Phan, Van Hiep Pham1, Thi Thanh Tra Nguyen, Ngoc Phuong Hoang, Du Khanh Nguyen, Bich Huong Nguyen, Thi Hang Pham, Thi Hoa Phung2,
1 BỆNH VIỆN TAI MŨI HỌNG TRUNG ƯƠNG
2 University of Medicine and Pharmacy, Vietnam National University, Hanoi

Main Article Content

Abstract

ABSTRACT


Objective: Overview of characteristics of treatment adherence in Allergic Rhinitis


Methods: A scoping review.


Results: Of the 51 relevant articles, 5 articles that met the selection criteria were included in the study. These studies were conducted in many different countries, all showing the complex characteristics of adherence to treatment of allergic rhinitis in real-life contexts, thereby providing initial suggestions for more effective, patient-centered intervention strategies to improve clinical outcomes and quality of life for patients.


Conclusion: Treatment adherence in allergic rhinitis patients is not a single issue of willpower, but a multifactorial challenge, reflecting the complexity of the disease and human behavior in real-life settings.


Keywords: Treatment adherence, Allergic rhinitis.

Article Details

References

1. Garrido-Fernández, S., et al., Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy. Immunotherapy, 2024. 16(10): p. 693-704.
2. Sousa‐Pinto, B., et al., Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study. Clinical & Experimental Allergy, 2025. 55(3): p. 226-238.
3. Zhang, J., et al., Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial. Annals of Allergy, Asthma & Immunology, 2024. 132(3): p. 346-354. e1.
4. Endaryanto, A. and R.A. Nugraha, Safety profile and issues of subcutaneous immunotherapy in the treatment of children with allergic rhinitis. Cells, 2022. 11(9): p. 1584.
5. Phinyo, P., et al., As-needed versus regular intranasal corticosteroid for allergic rhinitis: A systematic review and meta-analysis. Asian Pacific Journal of Allergy and Immunology, 2022. 40(3): p. 195-204.